Hepatitis C Drugs: The End of the Pegylated Interferon Era and the Emergence of All-Oral, Interferon-Free Antiviral Regimens: A Concise Review

Canadian Journal of Gastroenterology and Hepatology - Egypt
doi 10.1155/2014/549624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Interferon-Free Regimens for Chronic Hepatitis C—A Step Forward

Journal of Clinical and Experimental Hepatology
Hepatology
2013English

Review of Consensus Interferon in the Treatment of Chronic Hepatitis C

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

BMC Genomics
BiotechnologyGenetics
2014English

Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Sofosbuvir, Ribavirin and Pegylated Interferon for a Daclatasvir-Resistent Genotype 3 Hepatitis C Virus: Case Report and Review

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
2019English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research
Pharmacology
2005English

Interferon Graft Dysfunction: A Final Chapter for Interferon and Hepatitis C

Hepatology International
Hepatology
2014English

Hepatitis C Virus Clearance After Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child

Case Reports in Medicine
Medicine
2012English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy